Aik Han Goh

Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials

François Maltais, Sally Singh, Alison Donald et al. · Therapeutic Advances in Respiratory Disease · 2014 · 72 citations · Full text

Medicine, Pharmacotherapy, Exercise Physiology +16

Efficacy and Safety of SHR0302, a Highly Selective Janus Kinase 1 Inhibitor, in Patients with Moderate to Severe Atopic Dermatitis: A Phase II Randomized Clinical Trial

Yan Zhao, Litao Zhang, Yangfeng Ding et al. · American Journal of Clinical Dermatology · 2021 · 58 citations · Full text

Life Sciences, Dermatology, Immunology +16

Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study

Baili Chen, Jie Zhong, Xiuling Li et al. · Gastroenterology · 2022 · 48 citations

Medicine, Pharmacology, Pharmacotherapy +8

A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata

Cheng Zhou, Xiumin Yang, Bin Yang et al. · Journal of the American Academy of Dermatology · 2023 · 42 citations

Medicine, Pharmacology, Pharmacotherapy +8

Efficacy and safety of once-daily inhaled umeclidinium/vilanterol in Asian patients with COPD: results from a randomized, placebo-controlled study

J Zheng, Nanshan Zhong, Amy Newlands et al. · International Journal of COPD · 2015 · 35 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17